PLoS PathogensMicrobiologyPeer-reviewed journal article
Intracellular Pseudomonas aeruginosa persist and evade antibiotic treatment in a wound infection model
Stéphane PontiD, Flore Nilly, Laurence BerryiD, Anne BonhoureiD, Morgan A. AlfordiD, Mélissande Louis, Pauline NogaretiD, Manjeet Bains, Olivier LesouhaitieriD, Robert E. W. HancockiD, Patrick PlésiatiD, Anne‐Béatrice Blanc‐PotardiD
Abstract
Persistent bacterial infections evade host immunity and resist antibiotic treatments through various mechanisms that are difficult to evaluate in a living host. Pseudomonas aeruginosa is a main cause of chronic infections in patients with cystic fibrosis (CF) and wounds. Here, by immersing wounded zebrafish embryos in a suspension of P. aeruginosa isolates from CF patients, we established a model of persistent infection that mimics a murine chronic skin infection model. Live and electron microscopy revealed persisting aggregated P. aeruginosa inside zebrafish cells, including macrophages, at unprecedented resolution. Persistent P. aeruginosa exhibited adaptive resistance to several antibiotics, host cell permeable drugs being the most efficient. Moreover, persistent bacteria could be partly re-sensitized to antibiotics upon addition of anti-biofilm molecules that dispersed the bacterial aggregates in vivo. Collectively, this study demonstrates that an intracellular location protects P. aeruginosa in vivo from host innate immunity and antibiotics, and provides new insights into efficient treatments against chronic infections.
- organism: zebrafish
- assay: imaging
- research focus: host-pathogen & immune response
- approach: experimental assay
- approach: microscopy & imaging analysis
- Citations
- 31
- FWCI
- 7.43
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- How long does it take to cue a Pseudomonas aeruginosa chronic infection phenotype in the lab? Insights from transcriptome analysis in a cystic fibrosis lung model.
N. E. Harrington, F. Allen, … F. Harrison·bioRxiv·Jun 30, 2022
- Ranking of Major Classes of Antibiotics for Activity against Stationary Phase Pseudomonas aeruginosa and Identification of Clinafloxacin + Cefuroxime + Gentamicin Drug Combination that Eradicates Persistent P. aeruginosa Infection in a Murine Cystic Fibrosis Model
- A longitudinal evaluation of localised chronic Pseudomonas aeruginosa infection in cystic fibrosis rat models
Nicole Reyne, Bernadette Boog, … Martin Donnelley·BMC MicrobiologyPeer-reviewed·Mar 10, 2026
- In vitro persistence level reflects in vivo antibiotic survival of natural Pseudomonas aeruginosa isolates in a murine lung infection model
L. Verstraete, J. Aizawa, … P. Cos·bioRxiv·Oct 21, 2022
- Evasion of neutrophil-mediated bacterial clearance in Pseudomonas aeruginosa isolates from new-onset infections in cystic fibrosis children
Kelly Kwong, Sophia Goldman, … Dao M. Nguyen·bioRxiv·Sep 29, 2024
- Intracellular Pseudomonas aeruginosa within the airway epithelium of Cystic Fibrosis lung tissues
J. K. Malet, E. Faure, … D. Nguyen·bioRxiv·Aug 17, 2023